Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study.
[11C]-methionine PET
newly diagnosed glioblastoma
radiation therapy
supratotal resection
surgery
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
25 May 2021
25 May 2021
Historique:
received:
30
03
2021
revised:
20
05
2021
accepted:
21
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
(1) Background: We investigated the role of [11C]-methionine PET in a cohort of newly diagnosed glioblastoma multiforme (GBM) patients to evaluate whether it could modify the extent of surgical resection and improve radiation therapy volume delineation. (2) Methods: Newly diagnosed GBM patients, ages 18-70, with a Karnofsky performance scale (KPS) ≥ 70 with available MRI and [11C]-methionine PET were included. Patients were treated with different amounts of surgical resection followed by radio-chemotherapy. The role of [11C]-methionine PET in surgical and RT planning was analyzed. A threshold of SUVmax was searched. (3) Results: From August 2013 to April 2016, 93 patients were treated and included in this analysis. Residual tumor volume was detected in 63 cases on MRI and in 78 on [11C]-methionine PET, including 15 receiving gross total resection. The location of uptake was mainly observed in FLAIR abnormalities. [11C]-methionine uptake changed RT volume in 11% of patients. The presence of [11C]-methionine uptake in patients receiving GTR proved to influence survival (
Identifiants
pubmed: 34070698
pii: jcm10112313
doi: 10.3390/jcm10112313
pmc: PMC8198980
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Radiother Oncol. 2014 Sep;112(3):425-9
pubmed: 25308182
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1024-1028
pubmed: 29913253
Neurosurg Rev. 2019 Jun;42(2):471-479
pubmed: 29808321
Radiat Oncol. 2010 Jan 28;5:5
pubmed: 20109218
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):540-557
pubmed: 30519867
J Neurooncol. 2017 Oct;135(1):129-139
pubmed: 28689368
AJNR Am J Neuroradiol. 2008 Jun;29(6):1176-82
pubmed: 18388218
World Neurosurg. 2019 Jun;126:e270-e280
pubmed: 30797926
AJNR Am J Neuroradiol. 1992 Nov-Dec;13(6):1555-64
pubmed: 1332459
Biomed Phys Eng Express. 2021 Apr 30;7(3):
pubmed: 33887712
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):479-85
pubmed: 18834673
Neuroimaging Clin N Am. 2002 Nov;12(4):615-26
pubmed: 12687915
J Neurooncol. 2012 Jun;108(2):269-75
pubmed: 22362371
Surg Neurol Int. 2014 May 08;5:64
pubmed: 24991467
Oncotarget. 2017 Jun 28;8(40):67696-67708
pubmed: 28978064
EJNMMI Res. 2017 Dec;7(1):48
pubmed: 28560582
Radiother Oncol. 2016 Aug;120(2):241-7
pubmed: 27378734
Ann Nucl Med. 2001 Dec;15(6):471-86
pubmed: 11831394
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
J Neurosurg. 2001 Aug;95(2):190-8
pubmed: 11780887
Neuro Oncol. 2014 Jan;16(1):113-22
pubmed: 24285550
Clin Cancer Res. 2004 Nov 1;10(21):7163-70
pubmed: 15534088
J Neurosurg. 2016 Apr;124(4):977-88
pubmed: 26495941
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):64-74
pubmed: 16111573
Radiother Oncol. 2017 Mar;122(3):380-386
pubmed: 28110959
J Clin Oncol. 2010 Apr 10;28(11):1963-72
pubmed: 20231676
Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):133-40
pubmed: 26130232
World Neurosurg. 2014 Jul-Aug;82(1-2):e101-3
pubmed: 24534058